About
NirvaMed is an early-stage medical device company pioneering a novel treatment for ST-Elevation Myocardial Infarction (STEMI) heart attacks designed to substantially reduce heart muscle death and redefine the standard of care.
Technologies
Outlook
Android
Remote
Basis
Keywords
hypothermia
stemi
myocardial infarction
heart attack
reperfusion injury
medical device concept development
isolated heart cooling
medical device
medical equipment manufacturing
hospital & health care
medical devices
Company Information
-
Employees 2
-
Founded 2019
-
Total Funding $260000
Location
8500 Pillsbury Ave S, Minneapolis, Minnesota, United States, 55420-2246
